Pulmonx Cash on Hand 2019-2024 | LUNG

Pulmonx cash on hand from 2019 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Pulmonx Annual Cash on Hand
(Millions of US $)
2024 $102
2023 $117
2022 $141
2021 $180
2020 $232
2019 $28
2018 $4
Pulmonx Quarterly Cash on Hand
(Millions of US $)
2024-12-31 $102
2024-09-30 $108
2024-06-30 $115
2024-03-31 $116
2023-12-31 $117
2023-09-30 $117
2023-06-30 $136
2023-03-31 $153
2022-12-31 $141
2022-09-30 $157
2022-06-30 $162
2022-03-31 $170
2021-12-31 $180
2021-09-30 $200
2021-06-30 $210
2021-03-31 $219
2020-12-31 $232
2020-09-30 $40
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2018-12-31 $4
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.352B $0.084B
Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $36.709B 54.09
Hims & Hers Health (HIMS) United States $11.210B 183.25
Tempus AI (TEM) United States $10.954B 0.00
Inspire Medical Systems (INSP) United States $5.532B 107.78
IRhythm Technologies (IRTC) United States $3.734B 0.00
Privia Health (PRVA) United States $2.941B 245.10
Enovis (ENOV) United States $2.475B 16.49
Clover Health Investments (CLOV) United States $2.095B 0.00
Azenta (AZTA) United States $2.083B 96.98
Omnicell (OMCL) United States $1.845B 40.23
Schrodinger (SDGR) United States $1.580B 0.00
Phreesia (PHR) United States $1.577B 0.00
10x Genomics (TXG) United States $1.381B 0.00
Butterfly Network (BFLY) United States $0.859B 0.00
Fulgent Genetics (FLGT) United States $0.512B 0.00
Standard BioTools (LAB) United States $0.495B 0.00
Talkspace (TALK) United States $0.481B 285.00
TruBridge (TBRG) United States $0.423B 123.26
Nyxoah SA (NYXH) Belgium $0.353B 0.00
Health Catalyst (HCAT) United States $0.305B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.257B 0.00
American Well (AMWL) United States $0.174B 0.00
EUDA Health Holdings (EUDA) Singapore $0.097B 0.00
MDxHealth SA (MDXH) Belgium $0.085B 0.00
P3 Health Partners (PIII) United States $0.075B 0.00
111 (YI) China $0.072B 0.00
CareCloud (CCLD) United States $0.054B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
Outset Medical (OM) United States $0.044B 0.00
Zepp Health (ZEPP) China $0.042B 0.00
SHL Telemedicine (SHLT) Israel $0.038B 0.00
Zhongchao (ZCMD) China $0.034B 0.00
Movano (MOVE) United States $0.032B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Streamline Health Solutions (STRM) United States $0.015B 0.00
MSP Recovery (MSPR) United States $0.015B 0.00
Precipio (PRPO) United States $0.014B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Syra Health (SYRA) United States $0.005B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00